Overview
Zawamed is a company that conducts preclinical and clinical research, as well as training using in vitro models. They support clients in various industries, including cosmetics, feed, food, and pharmaceuticals, by assisting with funding acquisition, study design, execution, result interpretation, and report creation. Additionally, they provide services related to clinical trial cost settlements and patient compensation.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-06-24. Active
34 1020 3802 0000 1402 0292 7549
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
National Health Fund (NFZ) contracts
Zawamed has been an NFZ healthcare provider since 2021. In 2022 it is performing 1 contract worth USD 20.41. All its contracts were worth USD 20.41 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2022 |
|---|---|---|---|
| Podstawowa Opieka Zdrowotna | mazowieckie | 1 | USD 20.41 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Wioletta Krakówka (49) | 50 | $13,506.21 | 50% |
Piotr Roman Orłowski (41) | 50 | $13,506.21 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Countess Laboratoriessp. z o.o. | $99,221.13 | countess.pl | ||
| AM Lab Solutionssp. z o.o. | $100,896.70 | amsolutions.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| New Valuesp. z o.o. | $64,335.86 | new-value.pl | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Biostat Research And Developmentsp. z o.o. | $50,225.77 | biostat.com.pl | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| CannamedaiS.A. | $28,203.90 | cannamedai.com | ||
| Medaisp. z o.o. | $22,311.83 | medai.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-02-14 | Address change (Ul. Jana Olbrachta 19/38, 01-108, Warszawa → Ul. Marii Rodziewiczówny 9, 07-300, Ostrów Mazowiecka) | |
| 2024-02-14 | Share capital change (5,000.00 PLN → 100,000.00 PLN) | |
| 2020-05-05 | Address change (61, 16-075, Targonie Wielkie → Ul. Jana Olbrachta 19/38, 01-108, Warszawa) | |
| 2020-05-05 | PKD change (Removed: 55.10.Z, 86.21.Z, 86.22.Z, 86.90.A, 86.90.C, 86.90.D, 86.90.E, 87.10.Z, 87.30.Z; Added: 21.20.Z, 69.10.Z, 69.20.Z, 72.11.Z, 72.19.Z, 86.21, 86.22, 86.90) | |
| 2019-01-15 | Entered in the register |
FAQ
Last updated: 2026-04-10